ICCC · Immucell Corp · Documents

Jan 9

Current report 8-K

Financial results

Nov 21

Quarterly report 10-Q/A FY2022 Q1, ended Mar 31

Quarterly report for FY2022 Q1

Revenue $6M ▲ 46.1% Net income $513.29K Diluted EPS $0.07

Nov 21

Quarterly report 10-Q/A FY2022 Q2, ended Jun 30

Quarterly report for FY2022 Q2

Revenue $3.86M ▼ 15.0% Net loss $684.15K Diluted EPS -$0.09

Nov 21

Current report 8-K

Financial results

Nov 21

Quarterly report 10-Q FY2022 Q3, ended Sep 30

Quarterly report for FY2022 Q3

Revenue $4.8M ▼ 6.9% Net loss $655.08K Diluted EPS -$0.08

Nov 10

Current report 8-K Events of Nov 8

Financial results, Earlier financial statements no longer reliable

Nov 10

Late filing notice NT 10-Q

Late filing notice

Oct 5

Earnings call

Q3 2022 earnings call

Oct 5

Current report 8-K

Financial results

Aug 17

Current report 8-K Events of Aug 15

Entered into a material agreement, New debt or off-balance-sheet obligation

Aug 11

Current report 8-K

Financial results

Aug 11

Quarterly report 10-Q FY2022 Q2, ended Jun 30

Quarterly report for FY2022 Q2

Revenue $3.86M ▼ 15.0% Net loss $684.15K Diluted EPS -$0.09

Jul 28

Current report 8-K Events of Jul 27

Other events

Jul 7

Earnings call

Q2 2022 earnings call

Jul 7

Current report 8-K

Financial results

Jun 21

Current report 8-K/A Events of Jun 15

Shareholder vote results

Jun 16

Current report 8-K Events of Jun 15

Shareholder vote results

May 12

Earnings call

Q1 2022 earnings call

May 12

Current report 8-K

Financial results

May 12

Quarterly report 10-Q FY2022 Q1, ended Mar 31

Quarterly report for FY2022 Q1

Revenue $6M ▲ 46.1% Net income $735.67K Diluted EPS $0.09

Apr 28

Proxy statement DEF 14A Meeting Jun 15, 2022

Proxy statement

Apr 12

Proxy statement PRE 14A

Proxy statement

Apr 11

Current report 8-K

Financial results

Mar 30

Annual report 10-K FY2021, ended Dec 31

Annual report for FY2021

Revenue $19.24M ▲ 25.4% Net loss $78.29K Diluted EPS -$0.01

Mar 24

Current report 8-K

Entered into a material agreement, New debt or off-balance-sheet obligation

Feb 22

Earnings call

Q4 2021 earnings call

Feb 22

Current report 8-K

Financial results

Feb 11

Current report 8-K

Entered into a material agreement, Director or officer change, or executive pay

Jan 5

Current report 8-K

Financial results

Nov 15

Current report 8-K

Financial results

Nov 15

Quarterly report 10-Q FY2021 Q3, ended Sep 30

Quarterly report for FY2021 Q3

Revenue $5.15M ▲ 38.4% Net income $147.76K Diluted EPS $0.02

Oct 6

Earnings call

Q3 2021 earnings call

Oct 6

Current report 8-K

Financial results

Aug 24

Current report 8-K

Regulation FD disclosure, Other events

Aug 12

Earnings call

Q2 2021 earnings call

Aug 12

Current report 8-K

Financial results

Aug 12

Quarterly report 10-Q FY2021 Q2, ended Jun 30

Quarterly report for FY2021 Q2

Revenue $4.54M ▲ 53.1% Net income $141.11K Diluted EPS $0.02

Jul 7

Current report 8-K

Financial results

Jul 6

Current report 8-K Events of Jun 30

Entered into a material agreement, New debt or off-balance-sheet obligation

Jun 17

Current report 8-K Events of Jun 16

Shareholder vote results

May 13

Earnings call

Q1 2021 earnings call

May 13

Current report 8-K

Financial results

May 13

Quarterly report 10-Q FY2021 Q1, ended Mar 31

Quarterly report for FY2021 Q1

Revenue $4.11M ▼ 16.4% Net loss $441.3K Diluted EPS -$0.06

Apr 29

Proxy statement DEF 14A Meeting Jun 16, 2021

Proxy statement

Apr 15

Current report 8-K Events of Apr 14

Entered into a material agreement

Apr 7

Current report 8-K

Financial results

Mar 30

Annual report 10-K FY2020, ended Dec 31

Annual report for FY2020

Revenue $15.34M ▲ 11.8% Net loss $1.02M Diluted EPS -$0.14

Feb 23

Earnings call

Q4 2020 earnings call

Feb 23

Current report 8-K Events of Feb 22

Financial results

Jan 7

Current report 8-K

Financial results